Iron Lactate-Induced Osteomalacia in Association with Osteoblast Dynamics

Toxicologic Pathology

Volumn 31, Issue 6, 2003, Pages 646-654

  Matsushima, Shuuichi ^a   Tor, Mikinori ^a   Ozaki, Kiyokazu ^b   Narama, Isao ^b  

^a SHIONOGI AND CO LTD   (Japan)

^b SETSUNAN UNIVERSITY   (Japan)

Author keywords

hypophoshatemia; Iron lactate; osteoblast; osteoclast; osteomalacia; parathyroid hormone

Indexed keywords

FERROUS LACTATE; IRON DERIVATIVE; LACTIC ACID DERIVATIVE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSOCIATION; BLOOD CHEMISTRY; BONE EXAMINATION; BONE MINERALIZATION; BONE TURNOVER; CELL SURFACE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIETARY INTAKE; FEEDING; HISTOPATHOLOGY; HORMONE RELEASE; MALE; MOLECULAR DYNAMICS; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOID; OSTEOMALACIA; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RAT; SURFACE PROPERTY; THICKNESS; TIBIA; TRABECULAR BONE;

ADMINISTRATION, ORAL; ANIMALS; DIET; DISEASE MODELS, ANIMAL; IRON COMPOUNDS; LACTATES; MALE; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; OSTEOMALACIA; PARATHYROID HORMONE; PHOSPHORUS; RATS; RATS, SPRAGUE-DAWLEY; TIBIA;

ANIMALIA;

EID: 0242637137     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230390241990     Document Type: Article

References (26)

1. Barsotti G., Cupisti A., Morelli E., Meola M., Cozza V., Barsotti M., Giovannetti S. (1998). Secondary hyperparathyroidism in severe chronic renal failure is corrected by very-low dietary phosphate intake and calcium carbonate supplementation. Nephron 79: 137-141.
2. Brent GA, Leboff MS, Seely EW, Conlin PR, Brown EM (1988). Relationship between the concentration and rate of change of calcium and serum intact parathyroid hormone levels in nomal humans. J Clin Endocrinol Metab 67: 944-950.
3. Brown EM (1991). Extracellular calcium sensing, regulation of parathyroid cell function, and role of calcium and other irons as extracellular (first) messengers. Physiol Rwv 71: 371-411.
4. Brown EM, Thatcher JG, Watson EJ, Leombruno R. (1984). Extracellular calcium potentates the inhibitory effects of magnesium on parathyroid function in dispersed bovine parathyroid cells. Metabolism 33: 171-176.
5. Chen C., Ansat CS, Posillico JT, Brown EM (1987). Effect of extracellular calcium and magnesium on cytosolic calcium concentrations in fura-2-loaded bovine parathyroid cells. J Bone Min Res 2: 319-327.
6. Ebina Y., Okada S., Hamazaki S., Tada Y., Midorikawa O. (1991). Impairment of bone formation with aluminum and ferric nitrilotriacetate complexes. Calcif Tissue Int 48: 28-36.
7. Felsenfeld AJ, Llach F. (1993). Parathyroid gland function in chronic renal failure. Kidney Int 43: 771-789.
8. Fournier A., Moriniere P., Cohen-Solar M., Boudailliez B., Achard J., Marie A., Sebert J. (1991). Adynamic bone disease in uremia: may it be idiopathic? Is it an actual diseases. Nephron 58: 1-12.
9. Hayman AR, Cox TM (1994). Purple acid phosphatase of the human macrophage and osteoclast. Characterization, molecular properties, and crystallization of the recombinant di-iron-oxo protein secreted by baculovirus-infected insect cells. J Biol Chem 14: 1294-1300.
10. Hodsman AB, Sherrard DJ, Alfrey AC, Ott S., Brickman AS, Miller ML, Maloney NA, Coburn JW (1982). Bone aluminum and histomorphometric features of renal osteodystrophy. J Clin Endocrinol Metab 54: 539-546.
11. Kawabata T., Shimokawa I., Tomita M., Hirano T., Shindo H. (2002). Effects of caloric restriction on development of the proximal growth plate and metaphysic of the caput femoris in spontaneously hypertensive rats: microscopic and computer-assisted image analysis. Microsc Res Tech 15: 306-312.
12. Levin S., Semler D., Ruben Z. (1993). Effects of two weeks of feed restriction on some common toxicologic parameters in Sprague-Dawley rats. Toxicol Pathol 21: 1-14.
13. Lorenzo V., Martín M., Rufino M., Jiménez A., Malo AM, Sanchez E., Hernández D, Rodríguez, Torres A (2001). Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients. Am J Kidney Dis 37: 1260-1266.
14. Malluche HH, Faugere MC (1988). Aluminum-related bone disease. Blood Purif 1: 1-15.
15. Matsushima S., Hoshimoto M., Torii M., Ozaki K, Narama (2001). Iron lactate-induced osteopenia in male Sprague-Dawley rats. Toxicol Pathol 29: 623-629.
16. Narama I., Ozaki K., Matsushima S., Matsuura T. (1999). Eosinophilic gastroenterocolitis in iron lactate-overload rats. Toxicol Pathol 27: 318-324.
17. Narama I., Ozaki K., Matsuura T., Maruyama H. (1999). Topographic relation between iron-deposition and cytotoxic changes in iron lactate-overloaded rats. J Toxicol Pathol 12: 105-111.
18. Ott SM, Feist E., Andress DL, Liu CC, Sherrard DJ, Alfrey AC, Slatopolsky E., Howard GA (1987). Development and reversibility of aluminum-induced bone lesion in the rat. J Lab Clin Med 109: 40-47.
19. Parfitt AM (1983). The stereologic basis of bone histomorphometry. Theory of quantitative microscopy and reconstruction of the third dimension. In: Bone Histomorphometry. Techniques and Interpretations, Recker R (ed). CRC Press, Boca Raton, pp 53-87.
20. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H., Meunier PJ, Ott SM, Recker RR (1987). Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Min Res 2: 595-611.
21. Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M., Frame B., Rao DS (1983). Relationship between surface volume and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72: 1396-1409.
22. Parisien M., Charhon SA, Arlot M., Mainetti E., Chavassieux P., Chapuy MC, Meunier PJ (1988). Evidence for a toxic effect of aluminum on osteoblasts: a histomorhometric study in hemodialysis patients with aplastic bone disease. J Bone Miner Res 3: 259-267.
23. Posner AS, Blumenthal NC, Boskey AL (1986). Model of aluminum-induced osteomalacia: inhibition of apatite formation and growth. Kindey Int Suppl 18: 17-19.
24. Sato K., Nohtomi K., Demura H., Takeuchi A., Kobayashi T., Kazama J., Ozawa H. (1997). Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules. Bone 21: 57-64.
25. Woods CG (1994). Metabolic bone diseases. In: Diseases of Bone and Joints, Salisbury JR (ed). Chapman & Hall Medical, pp 236-285.
26. Yukihiro S., Okada S., Takeuchi K., Inoue H. (1995). Experimental osteodystrophy of chronic renal failure induced by aluminum- and ferric-nitrilotriacetate in wister rats. Pathol Int 45: 19-25.